Saby George

21.7k citations
170 papers · 5.0k · 3 hit papers · h-index 30

Impact in

Papers in

Saby George

157 papers receiving 4.9k citations

Saby George's Hit Papers

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial 2020 · 347 citations
3470+4+8Years since publication250500750

Peers

Saby George
Comparison fields: 5 of 100
  • Oncology 3.3k
  • Pulmonary and Respiratory Medicine 2.8k
  • Cancer Research 966
  • Immunology 692
  • Hematology 263
Replace Bartomeu Massutí with:
Bartomeu Massutí Spain
В. А. Горбунова Russia
Allen Lee Cohn United States
Jean-Pascal Machiels Belgium
Pablo Maroto Spain
Mohamed Hebbar France
Frede Donskov Denmark
Gladys Urbanowitz United States
Mark Kozloff United States
P. Koralewski Poland
Saby George relative to Bartomeu Massutí Spain Bartomeu Massutí's profile →
Citations per field
00.5×5.6×
Bartomeu Massutí · 1×
Citations per year

Countries citing papers authored by Saby George

Since Specialization
Citations

This map shows the geographic impact of Saby George's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saby George with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saby George more than expected).

Fields of papers citing papers by Saby George

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saby George. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saby George. The network helps show where Saby George may publish in the future.

Co-authors

The 25 scholars most cited alongside Saby George, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Saby George Line = papers co-authored together Saby George links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 170 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
Hit paper breakdown →
2014865
2 1998486
3
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial
Hit paper breakdown →
2020347
4
Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial
Hit paper breakdown →
2018274
5 2019186
6 2017184
7 2008184
8 2017176
9 2016142
10 2021102
11 201776
12 201768
13 202063
14 201962
15 201960
16 201859
17 201858
18 201455
19 202047
20 201546

About Saby George

Saby George is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Cancer Research and Molecular Biology, having authored 170 papers that have together received 5.0k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (91 papers), Cancer Immunotherapy and Biomarkers (67 papers), Bladder and Urothelial Cancer Treatments (39 papers), Cancer Genomics and Diagnostics (32 papers), Prostate Cancer Treatment and Research (23 papers), Economic and Financial Impacts of Cancer (22 papers), Renal and related cancers (20 papers) and Pancreatic and Hepatic Oncology Research (16 papers). The work is most often cited by research in Oncology (3.3k citations), Pulmonary and Respiratory Medicine (2.8k citations), Cancer Research (966 citations), Immunology (692 citations) and Hematology (263 citations). Saby George has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Brian I. Rini, Robert J. Motzer, Hans J. Hammers, Elizabeth R. Plimack, David F. McDermott, Ulka N. Vaishampayan, Ian M. Waxman, Toni K. Choueiri, Timothy M. Kuzel and Bruce G. Redman. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Genitourinary Cancer, The Oncologist and Journal for ImmunoTherapy of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact